Patent Assignment
Reel/Frame 064441/0575
Security Interest
Recorded: 2023-07-31
Pages: 26
Assignors
SORRENTO THERAPEUTICS, INC.
Executed: 2023-07-28
SCINTILLA PHARMACEUTICALS, INC.
Executed: 2023-07-28
Assignee
SCILEX HOLDING COMPANY
960 SAN ANTONIO ROAD, PALO ALTO, CALIFORNIA, 94303
Covered Properties
(170)
Transdermal Patch Containing Microneedles
Nanopatterned Medical Device with Enhanced Cellular Interaction
Transdermal Device Containing Microneedles
Method for Increasing the Permeability of an Epithelial Barrier
Device for Delivery of Rheumatoid Arthritis Medication
MEDICAL DEVICES FOR DELIVERY OF siRNA
Composite Microneedle Array Including Nanostructures Thereon
Injection Molded Microneedle Array and Method for Forming the Microneedle Array
Fully Human Antibodies that Bind to VEGFR2 and Methods of Use Thereof
Antibodies that Bind Epidermal Growth Factor Receptor (EGFR)
Antigen Binding Proteins that Bind Delta-Like 4 (DLL-4)
Antigen Binding Proteins That Bind Pd-L1
Antibodies Which Bind Insulin-Like Growth Factor Receptor-1 (IGF1R) and Methods of Use Thereof to Treat Cancer
Antigen Binding Proteins That Bind C-Met
Antigen Binding Proteins That Bind CCR2
Antigen Binding Proteins that Bind ErbB3
Anti-Infective Binding Proteins that Bind AIP2
Antigen Binding Proteins that Bind PD-1
Implantable Devices for Delivery of Bioactive Agents
Transdermal Delivery of High Viscosity Bioactive Agents
Anti-Infective Binding Proteins that Bind AIP2
Drug-Conjugates with a Targeting Molecule and Two Different Drugs
Fully Human Antibodies that Bind to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
Drug Delivery Device
Transdermal Drug Delivery Device
Microneedles With Improved Open Channel Cross-Sectional Geometries
Fully Human Anti-C-X-C Chemokine Receptor 3 (CXCR5) Antibodies
Fully Human Anti-CXC Chemokine Receptor 5 (CXCR5) Antibodies
Antibody Therapeutics That Bind Oprf
Draped Microneedle Array
Cartridge Portion of Transdermal Drug Delivery Apparatus and Methods
Antibody Drug Conjugates
Small Molecule C-Myc Inhibitors
Antibody Therapeutics That Bind CTLA4
Antibody Therapeutics That Bind CD137
Antibody Therapeutics That Bind CD137
Antibody Therapeutics That Bind CD47
Antibody Therapeutics That Bind TIM3
Antibody Therapeutics That Bind JAG1
Antibody Therapeutics That Bind Psma
Antibody Therapeutics That Bind CD38
Antibody Therapeutics That Bind CD123
Antibody Therapeutics That Bind CD123
Antibody Therapeutics That Bind CD38
Antigen Binding Proteins that Bind CCR2
Antigen Binding Proteins that Bind ErbB3
Antibody Therapeutics That Bind LAG3
Intracellular Delivery Compounds
Antibody Therapeutics That Bind CD147
Transdermal Drug Delivery Apparatus and Methods
Controller Portion of Transdermal Drug Delivery Apparatus and Methods
Receptacle Portion of Transdermal Drug Delivery Apparatus and Methods
Chemically-Locked Bispecific Antibodies
Antigen Binding Proteins That Bind WISP1
Chemically-Locked Bispecific Antibodies
Device for Delivery of Rheumatoid Arthritis Medication
Medical Devices for Delivery of siRNA
Composite Microneedle Array Including Nanostructures Thereon
Transdermal Delivery of High Viscosity Bioactive Agents
Method for Increasing the Permeability of an Epithelial Barrier
Antigen Binding Proteins That Bind Pd-L1
Anti-Infective Binding Proteins That Bind AIP2
Antibody Therapeutics That Bind STAT3
Antigen Binding Proteins That Bind Pd-1
Antibody Drug Conjugates Having Derivatives of Amatoxin as the Drug
Antigen Binding Proteins That Bind Pd-L1
Methods for Treating Subjects Having a Cxc Chemokine Receptor 5 (CXCR5)-Responsive Cancer by Administering Fully Human Anti-CXCR5 Antibodies
Drug Delivery Methods Targeting the Lymphatic System
Application:
15/733,817 →
Publication:
US 2021/0228853
Methods for Better Delivery of Active Agents to Tumors
Methods for Lymphatic Delivery of Active Agents
Antibody Therapeutics That Bind TIM3
CELL PENETRATING PEPTIDE INHIBITORS OF p53-MDM2 INTERACTION
Increased Bioavailability of Transdermally Delivered Agents
Antigen Binding Proteins that Bind CCR2
CD38 Antibody Drug Conjugate
Device for Delivery of Rheumatoid Arthritis Medication
Medical Devices for Delivery of siRNA
Composite Microneedle Array Including Nanostructures Thereon
Disulfide Bridging Conjugates
Antibody Therapeutics That Bind CD38
Microneedle Array Assembly, Drug Delivery Device and Method for Administering Liquid Across a Broad Area at Low Pressure
Microneedle Array Assembly and Fluid Delivery Apparatus Having Such an Assembly
Antigen Binding Proteins That Bind Pd-L1
Antibody Therapeutics That Bind CD123
Fully Human Anti-C-X-C Chemokine Receptor 3 (CXCR3) Antibodies and Methods of Use Thereof
Antigen Binding Proteins That Bind Pd-L1
Cartridge Portion of Transdermal Drug Delivery Apparatus and Methods
CD-38 Directed Chimeric Antigen Receptor Constructs
Variant Antibodies That Bind OX40
Transdermal Drug Delivery Device
Variant Antibodies That Bind AIP2
Methods for Blocking an Interaction Between Notch-1 and Delta-Like 4 (Dll-4) by Administering a Ddl-4 Antibody
Antibody Therapeutics That Bind CTLA4
Transdermal Delivery of High Viscosity Bioactive Agents
Transdermal Drug Delivery Apparatus and Methods
Antibody Therapeutics That Bind CD137
Process for Dna Integration Using Rna-Guided Endonucleases
Application:
16/288,052 →
Publication:
US 2020/0224160
Anti-OX40 Binding Proteins
Nanopatterned Medical Device with Enhanced Cellular Interaction
Antigen Binding Proteins That Bind WISP1
Anti-KRAS Binding Proteins
Chemically-Locked Bispecific Antibodies
Method for Increasing Permeability of a Cellular Layer of Epithelial Cells
Antigen Binding Proteins That Bind C-Met
Cell Internalizing Compounds
Fluid Delivery Apparatus Having a Gas Extraction Device and Method of Use
Attachment Band for a Fluid Delivery Apparatus and Method of Use
Fluid Delivery Apparatus and Method of Assembly
Application Device for a Fluid Delivery Apparatus and Method of Use
A Fluid Delivery Apparatus Having a Controller Assembly and Method of Use
Method for Administering a Medicament Suitable for Treating a Migraine or Cluster Headache
Anti-Cancer Phosphorothioate-Coupled Peptide Conjugates and Methods of Using the Same
Fluid Delivery Apparatus Having a Gas Extraction Device and Method of Use
Antigen Binding Proteins that Bind PD-1
Fluid Delivery Apparatus and Method of Assembly
Device for Delivery of Rheumatoid Arthritis Medication
Methods for Lymphatic Delivery of Active Agents
Application:
16/925,548 →
Publication:
US 2020/0338329
Increased Bioavailability of Transdermally Delivered Agents
Anti-OX40 Binding Proteins
Disulfide Bridging Conjugates
Application:
17/008,432 →
Publication:
US 2021/0052738
Dimeric Antigen Receptors
Antibody Therapeutics that Bind CD38
Methods for Better Delivery of Active Agents to Tumors
Application:
17/022,855 →
Publication:
US 2021/0052871
Composite Microneedle Array Including Nanostructures Thereon
Drug-Conjugates With a Targeting Molecule and Two Different Drugs
Compositions and Methods Comprising an Anti-CD47 Antibody in Combination with a Tumor Targeting Antibody
Application:
17/112,587 →
Publication:
US 2021/0221886
Variant Antibody That Binds Cd38
Application:
17/127,766 →
Publication:
US 2021/0130484
Fluid Delivery Apparatus Having a Gas Extraction Device and Method of Use
Antigen Binding Proteins that Bind PD-L1
Antibody Therapeutics That Bind CD123
Cartridge Portion of Transdermal Drug Delivery Apparatus and Methods
Application:
17/166,391 →
Publication:
US 2021/0196567
Transdermal Drug Delivery Device
Antibody Drug Conjugates Having Derivatives of Amatoxin As The Drug
Application:
17/240,700 →
Publication:
US 2021/0260211
Antigen Binding Proteins That Bind PD-L1
Perineural Administration of Resiniferatoxin for Treatment of Maladaptive Pain
Methods for Treating Parkinson's Disease by Administering Resiniferatoxin
Fully Human Antibodies That Bind to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) and Methods of Use Thereof for Treatment
Implantable Devices for Delivery of Bioactive Agents
Transdermal Delivery of High Viscosity Bioactive Agents
Application:
17/408,699 →
Publication:
US 2022/0008703
Variant Antibodies That Bind OX40
Antigen Binding Proteins that Bind BCMA
Application:
17/412,089 →
Publication:
US 2021/0388097
Method for Treating Osteoarthritis Pain by Administering Resiniferatoxin
Improved Process for Dna Integration Using Rna-Guided Endonucleases
Application:
17/434,209 →
Publication:
US 2022/0169984
Improved Process for Integration of Dna Constructs Using Rna-Guided Endonucleases
Application:
17/438,039 →
Publication:
US 2022/0145333
MEDICAL DEVICES FOR DELIVERY OF siRNA
Application:
17/464,402 →
Publication:
US 2021/0393934
Antibody Therapeutics that Bind CTLA4
Application:
17/482,138 →
Publication:
US 2022/0002415
Antigen Binding Proteins that Bind c-Met
Application:
17/482,140 →
Publication:
US 2022/0002422
Antibody Therapeutics That Bind CD137
Application:
17/499,127 →
Publication:
US 2022/0025064
Nanopatterned Medical Device with Enhanced Cellular Interaction
Microneedle Array Assembly, Drug Delivery Device and Method for Administering Liquid Across a Broad Area at Low Pressure
Application:
17/509,182 →
Publication:
US 2022/0040465
CD38 Antibody Drug Conjugate
Application:
17/518,375 →
Publication:
US 2022/0118105
Method for Administering a Medicament Suitable for Treating a Migraine or Cluster Headache
Application:
17/538,838 →
Publication:
US 2022/0080173
Antigen Binding Proteins that Bind PD-1
Application:
17/554,926 →
Publication:
US 2022/0242954
Transdermal Drug Delivery Apparatus and Methods
Application:
17/563,234 →
Publication:
US 2022/0331571
Formulation of Resiniferatoxin
Application:
17/569,340 →
Publication:
US 2022/0370405
Chemically-Locked Bispecific Antibodies
Application:
17/585,378 →
Publication:
US 2022/0144971
Engineered Variant Antibodies that Bind CD38
Application:
17/599,377 →
Publication:
US 2022/0144966
Cannabidiol Pharmaceutical Compositions
Application:
17/601,357 →
Publication:
US 2022/0183999
Activatable Multi-Specific Antigen Binding Protein Complexes
Application:
17/602,908 →
Publication:
US 2022/0324974
Heterodimeric Antibodies That Bind to CD38 and CD3
Application:
17/622,087 →
Publication:
US 2022/0363758
Dimeric Antigen Receptors (DAR) that Bind BCMA
Application:
17/686,261 →
Publication:
US 2022/0251168
Microneedle Array Assembly and Fluid Delivery Apparatus Having Such an Assembly
Fluid Delivery Apparatus Having a Controller Assembly and Method of Use
Application:
17/737,270 →
Publication:
US 2022/0355088
Method of Treating Cancer by Administration of an Anti-Pd-1 or Anti-Pd-L1 Therapeutic Agent via a Lymphatic Delivery Device
Application:
17/781,672 →
Publication:
US 2023/0001170
Strap Component for a Fluid Delivery Apparatus
Patent:
810,604 →
Application:
29/587,921 →
Collet for a Fluid Delivery Apparatus
Patent:
831,198 →
Application:
29/587,922 →
Cartridge for a Fluid Delivery Apparatus
Patent:
836,774 →
Application:
29/587,923 →
Fluid Delivery Apparatus
Patent:
819,197 →
Application:
29/587,924 →
Applicator Device for a Fluid Delivery Apparatus
Patent:
810,927 →
Application:
29/587,926 →
Carrying Case
Patent:
810,421 →
Application:
29/587,927 →
Related Assignments
(13)
Other recorded transfers of the patents in this record — the chain of ownership.
Name Change
Feb 3, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 034880/0674 →
Name Change
Feb 3, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 034880/0634 →
Corrective Assignment to Correct the Assignee Previously Recorded on Reel 030497 Frame 0439. Assignor(S) Hereby Confirms the Assignee Name Should Read: Sorrento Therapeutics, Inc..
May 22, 2017
From: GROS, EDWIGE; ZHANG, YANLIANG; ZHOU, HEYUE; GASTWIRT, RANDY
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 042525/0343 →
Corrective Assignment to Correct the Assignee Name with Comma Previously Recorded at Reel: 030406 Frame: 0418. Assignor(S) Hereby Confirms the Assignment.
May 22, 2017
From: ZHOU, HEYUE; GASWIRT, RANDY; SWANSON, BARBARA A.; GRAY, JOHN DIXON
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 042525/0180 →
Assignment of Assignor's Interest
Sep 18, 2018
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 046899/0689 →
Security Interest
Nov 7, 2018
From: SORRENTO THERAPEUTICS, INC.; TNK THERAPEUTICS, INC.; CONCORTIS BIOSYSTEMS, CORP.; ARK ANIMAL HEALTH, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 047446/0335 →
Release of Security Interest
Jul 31, 2020
From: OAKTREE FUND ADMINISTRATION, LLC
To: SORRENTO THERAPEUTICS, INC.; TNK THERAPEUTICS, INC.; CONCORTIS BIOSYSTEMS, CORP.; ARK ANIMAL HEALTH, INC.
Reel/Frame 053368/0577 →
Assignment of Assignor's Interest
May 9, 2022
From: GASTWIRT, RANDY; ZHOU, HEYUE; GRAY, JOHN DIXON; LU, GUODI
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 059869/0651 →
Security Interest
Apr 6, 2023
From: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
To: JMB CAPITAL PARTNERS LENDING, LLC
Reel/Frame 063283/0063 →
Release of Security Interest
Aug 11, 2023
From: JMB CAPITAL PARTNERS LENDING, LLC
To: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
Reel/Frame 064571/0848 →
Termination and Release of Security Interest in Intellectual Property
Sep 21, 2023
From: SCILEX HOLDING COMPANY
To: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
Reel/Frame 065017/0844 →
Assignment of Assignor's Interest
May 24, 2024
From: SORRENTO THERAPEUTICS, INC.
To: VIVASOR, INC.
Reel/Frame 067521/0619 →
Assignment of Assignor's Interest
May 24, 2024
From: SORRENTO THERAPEUTICS, INC.
To: VIVASOR, INC.
Reel/Frame 067529/0019 →